M&A Deal Summary |
|
|---|---|
| Date | 2025-08-27 |
| Target | Hennessy Research Associates |
| Sector | Business Services |
| Buyer(s) | Kemin Industries |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 2,000 |
Kemin Industries, Inc. is a global nutritional ingredient company that uses science to create solutions and products. The company provides over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. Kemin has more than 2,000 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 9 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 7 of 7 |
| State: Kansas M&A | 1 of 1 |
| Country: United States M&A | 7 of 7 |
| Year: 2025 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-05-12 |
Bactana
Farmington, Connecticut, United States Bactana is a research-driven company specializing in advancements in intestinal health and fermentation technology. The company has patented the use of a select group of microbes that manipulate the microbial ecology of animals to enhance the interaction of the microbiome, immune system, and metabolism (immunometabolism). It creates therapies for pets to treat metabolic conditions and digestive disorders, while also developing sustainable products for use in livestock production that reduce natural resource utilization, greenhouse gas emissions, and antibiotic usage. Bactana is based in Farmington, Connecticut. |
Buy | - |
